Talia Golan

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Histologic Spectrum of BRCA-Associated Pancreatic Ductal Adenocarcinoma : A Descriptive Morphologic Study

  Human Pathology · 2026-06-01

• The SPIN Score, a simple clinical score to predict pain response following celiac plexus radiosurgery for retroperitoneal cancer pain.

  Journal of Clinical Oncology · 2026-05-27

• AI-driven RNA-based homologous recombination deficiency algorithm to predict first-line platinum response in metastatic pancreatic cancer.

  Journal of Clinical Oncology · 2026-05-27

• Phase IIb randomized trial of FOLFIRINOX plus ibrilatazar (ABTL0812) versus placebo as first-line treatment in metastatic pancreatic cancer: An analysis from the PanC-ASAP study.

  Journal of Clinical Oncology · 2026-05-27

• Tumor-of-origin prediction using methylation signals from plasma cell-free DNA (cfDNA): Real-world experience in Asia and the Middle East (AME).

  Journal of Clinical Oncology · 2026-05-27

• Abstract 6488: Dual targeting of PARP and RAS enhances antitumor activity in pancreatic cancer

  Cancer Research · 2026-04-03

• Abstract 1273: Antitumor activity of PARPi and POLQi combination therapy in a BRCA-mutated PDAC model.

  Cancer Research · 2026-04-03

• Abstract 2447: Epigenomic liquid biopsy-based biomarkers of platinum and PARP inhibitor response in patients with germ line BRCA-associated PDAC: A pilot study

  Cancer Research · 2026-04-03

• Abstract 1982: Genomic analyses of patient-derived xenografts reveal novel molecular subsets of PDAC and their association with clinical features.

  Cancer Research · 2026-04-03

• Supplementary Table S1 from A Phase II Trial of an Extended-Release siRNA Implant Targeting <i>KRAS</i><sup>G12D/V</sup> in Locally Advanced Pancreatic Cancer

  2026-03-16

• Supplementary Figure S1 from A Phase II Trial of an Extended-Release siRNA Implant Targeting <i>KRAS</i><sup>G12D/V</sup> in Locally Advanced Pancreatic Cancer

  2026-03-16

• Data from A Phase II Trial of an Extended-Release siRNA Implant Targeting <i>KRAS</i><sup>G12D/V</sup> in Locally Advanced Pancreatic Cancer

  2026-03-16

• Exploring per-base quality scores as a surrogate marker of cell-free DNA fragmentome

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-03-10

• A Phase II Trial of an Extended-Release siRNA Implant Targeting <i>KRAS</i> G12D/V in Locally Advanced Pancreatic Cancer

  Clinical Cancer Research · 2026-01-13 · 4 citations

• Long-term efficacy of celiac plexus radiosurgery for pancreatic cancer pain: An international phase II trial.

  Journal of Clinical Oncology · 2026-01-10

• Supplementary table 3 from Spectrum of Response to Platinum and PARP Inhibitors in Germline &lt;i&gt;BRCA&lt;/i&gt;–Associated Pancreatic Cancer in the Clinical and Preclinical Setting

  2025-12-11

• Supplementary Table S2 from Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis

  2025-12-11

• Supplementary figure 2 from Spectrum of Response to Platinum and PARP Inhibitors in Germline &lt;i&gt;BRCA&lt;/i&gt;–Associated Pancreatic Cancer in the Clinical and Preclinical Setting

  2025-12-11

• Supplementary Figure S3 from Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis

  2025-12-11

• Supplementary Figure S5 from Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis

  2025-12-11